Skip to content
Home
About
About Project ECHO®
FAQ
Apply to ECHO COE
Contact
ECHO Research
ECHO Care of the Elderly Team
Provincial ECHO
About
Apply to ECHO COE
Didactic Curriculum
2023
2022
2021
2020
2019
2018
National ECHO
Apply to National ECHO
GEMH Didactic Curriculum
GEMH 2021
GEMH 2023
GEMH Clinical Resources
Long Term Care – COVID-19
LTC COVID-19 Curriculum
LTC COVID-19 Resources
My Account
Login
Search for:
Search
Category:
Incontinence
Home
Care of the Elderly - Resources
Incontinence
Search Clinical Resources
Search
Incontinence
2012 Update: Guidelines for Adult Urinary Incontinence Collaborative Consensus Document for the Canadian Urological Association
Additional Resources
Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points.
Development of a core set of outcome measures for OAB treatment
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.
Flexible-Dose Fesoterodine in Elderly Adults with Overactive Bladder: Results of the Randomized, Double-Blind, Placebo- Controlled Study of Fesoterodine in an Aging Population Trial
Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada
The efficacy and tolerability of the Beta 3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients
The neural control of micturition
Results after sacral nerve stimulation for chronic constipation.
You are here:
KB Home
Articles by Topic
Incontinence
Category - Incontinence
Articles
2012 Update: Guidelines for Adult Urinary Incontinence Collaborative Consensus Document for the Canadian Urological Association
Additional Resources
Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points.
Development of a core set of outcome measures for OAB treatment
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.
Flexible-Dose Fesoterodine in Elderly Adults with Overactive Bladder: Results of the Randomized, Double-Blind, Placebo- Controlled Study of Fesoterodine in an Aging Population Trial
Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada
The efficacy and tolerability of the Beta 3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients
The neural control of micturition
Results after sacral nerve stimulation for chronic constipation.
+ 3 Articles
Show all articles
